Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ClearPoint Neuro, Inc.CLPT · Entity 2367 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ClearPoint Neuro, Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 12,820 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 12,820 · Balance 12,820 F1: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
F2: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 21, 2026 Filed May 26, 2026 20:30 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 12,820 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-239443 · ownership.xml · derivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,820 Underlying: Common Stock · 12,820 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:30 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 12,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-234562 · ownership.xml · derivative · entry 2 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,417 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| May 19, 2026 Filed May 21, 2026 20:30 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 12,417 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-234562 · ownership.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,801 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 22, 2025, the reporting person was granted 12,417 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| May 22, 2025 Filed May 23, 2025 21:48 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 12,417 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-077162 · ownership.xml · derivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,417 Underlying: Common Stock · 12,417 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2026 annual meeting of stockholders. Read SEC document |
| May 16, 2025 Filed May 19, 2025 20:38 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 21,093 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-074436 · ownership.xml · derivative · entry 2 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,093 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| May 16, 2025 Filed May 19, 2025 20:38 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 21,093 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-074436 · ownership.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 52,384 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. On May 16, 2024, the reporting person was granted 21,093 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date. Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 21:54 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 193 | $15.38 | $2,968.34 |
DisclosureSEC source: 0000950170-25-001307 · ownership.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,291 F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at December 31, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 20:23 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 264 | $11.21 | $2,959.44 |
DisclosureSEC source: 0001285550-24-000115 · wk-form4_1727900574.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,098 F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at September 30, 2024. Read SEC document |
| July 01, 2024 Filed Jul 2, 2024 21:22 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 550 | $5.39 | $2,964.50 |
DisclosureSEC source: 0001285550-24-000087 · wk-form4_1719955342.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,834 F1 · price: These shares were issued pursuant to the issuer's Fifth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at June 28, 2024. Read SEC document |
| May 16, 2024 Filed May 17, 2024 20:20 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 21,093 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-24-000065 · wk-form4_1715977211.xml · derivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,093 Underlying: Common Stock · 21,093 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2025 annual meeting of stockholders. Read SEC document |
| May 14, 2024 Filed May 15, 2024 13:17 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionRestricted Stock Units · Derivative | 17,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-24-000054 · wk-form4_1715779047.xml · derivative · entry 2 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,153 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders. F2 · derivative.expiration_date: On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders. Read SEC document |
| May 14, 2024 Filed May 15, 2024 13:17 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | Exercise / conversionCommon Stock | 17,153 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001285550-24-000054 · wk-form4_1715779047.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,284 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 01, 2024 Filed Apr 2, 2024 20:42 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 436 | $6.80 | $2,964.80 |
DisclosureSEC source: 0001285550-24-000041 · wk-form4_1712090533.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,131 F1 · price: These shares were issued pursuant to the issuer's Fourth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 28, 2024. Read SEC document |
| May 25, 2023 Filed May 26, 2023 18:10 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantRestricted Stock Units · Derivative | 17,153 | $0.00 | $0.00 |
DisclosureSEC source: 0001285550-23-000060 · wf-form4_168512461255569.xml · derivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,153 Underlying: Common Stock · 17,153 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of CLPT common stock. F2 · derivative.exercise_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders. F2 · derivative.expiration_date: The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:31 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 6,179 | $0.00 Strike: $9.71 | $0.00 |
DisclosureSEC source: 0001420506-22-001140 · doc4_1013.xml · derivative · entry 2 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,179 Underlying: Common Stock · 6,179 shares Expires 2032-05-25 F2 · derivative.exercise_date: The shares subject to this option will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:31 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 9,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001420506-22-001140 · doc4_1013.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,695 F1 · price: The shares are restricted stock and will vest in full on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2023 annual meeting of stockholders Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:24 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantStock Options (right to buy) · Derivative | 6,696 | $0.00 Strike: $17.51 | $0.00 |
DisclosureSEC source: 0001420506-21-001450 · doc4_976.xml · derivative · entry 2 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,696 Underlying: Common Stock · 6,696 shares Expires 2031-11-02 F2 · derivative.exercise_date: The shares subject to this option will vest in full on the first anniversary of the grant date. Read SEC document |
| November 02, 2021 Filed Nov 3, 2021 22:24 UTC | ClearPoint Neuro, Inc. CLPT · Entity 2367 | GrantCommon Stock | 3,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001420506-21-001450 · doc4_976.xml · nonDerivative · entry 1 LIAU LINDA M. · CIK 0001890712 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,426 F1 · shares: The shares are restricted stock and will vest in full on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.